Bernard Fox: The Hottest Area of Immuno Oncology Meeting
Bernard Fox, Co-Founder/President/CEO at UbiVac, shared a post by Vivenko post on LinkedIn, adding:
“JULY 30th ABSTRACT DEADLINE!!
HANDS DOWN, The HOTTEST area of immuno oncology is the Dark Genome!!
Working on Dark Genome cancer vaccines???? You should be in Milan on Oct. 1st!!
The world’s experts on this topic will be speaking!!
This is a very small and AMAZING meeting with the hottest cancer immunotherapy science!
Dark Genome -derived non-canonical cancer antigens/ Dark Proteome, Dark Matter, Dark Peptidome + TAA, LSA, and neoantigens.
Still opportunities to sponsor!”
Quoting Vivenko‘s post:
“LAST CHANCE – Call for Abstracts!
Submit your abstract for the upcoming edition of VAX ON – Vaccines: Present and Future in Oncology, taking place on October 1st, 2025, in Milan, Italy.
This is an opportunity to present your research to a global audience of experts and engage in valuable scientific dialogue and exchange.
The best abstracts will be selected by the Scientific Board for poster and oral communication presentations. Posters will be displayed during the event and presented by the authors in the final session.
Abstract Topics Include:
- Neoantigens
- mRNA Vaccines
- Dark Matter
- Peptide Vaccines
- Vaccines with anti-PD-1
- Combination IO with Vaccines
For detailed submission instructions, please refer to the Authors’ Guidelines.
Submit your abstract to: [email protected]
Deadline: July 30th, 2025.”
More posts featuring Bernard Fox.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023